Anwel Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 13 Year,
- Last Filing with ROC 31 Mar 2024
About Anwel Life Sciences
Anwel Life Sciences Private Limited (ALSPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 February 2012 and has a history of 13 years. Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Dilipbhai Khimani, Rameshbhai Khimani, and Sanjaykumar Khimani serve as directors at the Company.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230GJ2012PTC069060
-
Company No.
069060
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Feb 2012
-
Date of AGM
05 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Anwel Life Sciences Private Limited offer?
Anwel Life Sciences Private Limited offers a wide range of products and services, including Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Ayurvedic & Herbal Extracts, Herbal Extracts, Ayurvedic & Herbal Health Supplement, Herbal Juice, Tea & Coffee, Coffee Powder, Cooking Spices and Masala, Whole Spices.
Who are the key members and board of directors at Anwel Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dilipbhai Khimani
|
Whole-Time Director | 16-Feb-2012 | Current |
|
Rameshbhai Khimani
|
Whole-Time Director | 16-Feb-2012 | Current |
|
Sanjaykumar Khimani
|
Whole-Time Director | 16-Feb-2012 | Current |
Financial Performance of Anwel Life Sciences.
Anwel Life Sciences Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anwel Life Sciences?
In 2017, Anwel Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Anwel Life Sciences?
Unlock and access historical data on people associated with Anwel Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anwel Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anwel Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.